Related Experiment Video
Updated: Aug 8, 2026

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients
Published on: March 29, 2022
The Long-Term Patient Journey with DIMS Spectacle Lenses: A Mixed-Methods Study of Satisfaction, Adherence and
Tsz Wing Leung1,2, Han Yu Zhang3,4, Carly Siu Yin Lam5
1Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong. tw15leung@polyu.edu.hk.
Purpose:
While defocus incorporated multiple segments (DIMS) spectacle lenses are clinically proven effective in slowing myopia progression, the long-term, real-world patient experience is poorly understood. This study aimed to provide both quantitative and qualitative analyses of the wearer experience in a long-term cohort of DIMS wearers.
Methods:
This retrospective, convergent parallel mixed-methods study included 63 former child participants (now aged 17-23 years) who participated in the previous DIMS spectacle lenses clinical trial 8-10 years earlier. Data were collected 2 years after the final clinical trial concluded. A quantitative online questionnaire assessed wearer experience, while in-depth, semi-structured phone interviews explored the lived wearer journey. Predictors of satisfaction were identified using multiple linear regression and qualitative transcripts were analysed using a systematic thematic approach.
Results:
Quantitative analysis revealed high satisfaction, with 88.9% of wearers satisfied or very satisfied and 90.4% believing in the efficacy of DIMS spectacle lenses. Regression analysis identified Maintenance and Durability as the strongest predictors of long-term satisfaction, alongside positive perceptions of appearance (adjusted R2 = 0.50, p < 0.001). Qualitative analysis revealed a patient journey defined by parent-driven initiation, a manageable sensory adaptation period and strong perceived efficacy based on personal experience. However, only one-third of participants had continued DIMS use; a decision driven overwhelmingly by the high cost of the spectacles.
Conclusion:
DIMS spectacle lenses provide a highly positive long-term wearer experience. However, the high cost of the spectacles creates a dominant socioeconomic barrier to treatment continuity, highlighting a critical gap between clinical success and access outside the trial setting.